Laurent Bedenne

15.5k total citations · 7 hit papers
158 papers, 10.4k citations indexed

About

Laurent Bedenne is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Laurent Bedenne has authored 158 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 75 papers in Pulmonary and Respiratory Medicine and 60 papers in Surgery. Recurrent topics in Laurent Bedenne's work include Gastric Cancer Management and Outcomes (57 papers), Colorectal Cancer Treatments and Studies (44 papers) and Esophageal Cancer Research and Treatment (37 papers). Laurent Bedenne is often cited by papers focused on Gastric Cancer Management and Outcomes (57 papers), Colorectal Cancer Treatments and Studies (44 papers) and Esophageal Cancer Research and Treatment (37 papers). Laurent Bedenne collaborates with scholars based in France, Belgium and Germany. Laurent Bedenne's co-authors include Olivier Bouché, Thierry Conroy, Franck Bonnetain, Valérie Boige, Marc Ychou, Philippe Rougier, P. Rougier, Éric François, C. Mariette and Jean‐François Seitz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Laurent Bedenne

152 papers receiving 10.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

2011 1.5k citations Marc Ychou, Valérie Boige et al. Journal of Clinical Oncology profile →
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203

2006 1.3k citations Thierry Conroy, Franck Bonnetain et al. Journal of Clinical Oncology profile →
Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102

2007 868 citations Laurent Bedenne, Pierre Michel et al. Journal of Clinical Oncology profile →
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.

1997 709 citations J.-F. Bosset, C Milan et al. Journal of Clinical Oncology profile →
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

2008 501 citations Bruno Chauffert, F. Mornex et al. Annals of Oncology profile →
Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901

2014 413 citations C. Mariette, Laëtitia Dahan et al. Journal of Clinical Oncology profile →
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

2014 276 citations Thierry Conroy, Marie‐Pierre Galais et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Laurent Bedenne

Since Specialization

Citations

This map shows the geographic impact of Laurent Bedenne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Bedenne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Bedenne more than expected).

Fields of papers citing papers by Laurent Bedenne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Bedenne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Bedenne. The network helps show where Laurent Bedenne may publish in the future.

Co-authorship network of co-authors of Laurent Bedenne

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Bedenne. A scholar is included among the top collaborators of Laurent Bedenne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Bedenne. Laurent Bedenne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer 2017 ·European Journal of Cancer ·Caroline Mollévi, Sophie Gourgou, Marie‐Pierre Galais, Jean‐Luc Raoul, Olivier Bouché, Jean‐Yves Douillard, Antoine Adenis, Pierre-Luc Etienne, Béata Juzyna, Laurent Bedenne, Thierry Conroy	14
2	An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma 2016 ·BMJ Open ·Amélie Anota, Mathieu Boulin, Tienhan Sandrine Dabakuyo‐Yonli, Patrick Hillon, Jean–Pierre Cercueil, Anne Minello, Jean–Louis Jouve, Xavier Paolettí, Laurent Bedenne, Boris Guiu, Franck Bonnetain	11
3	Prognostic factor analysis for elderly patients treated for metastatic colorectal cancer in the randomized phase II trial PRODIGE 20 2016 ·Annals of Oncology ·Thomas Aparicio, O. Bouché, Éric François, E. Maillard, Sylvie Kirscher, Julien Taı̈eb, Pierre-Luc Etienne, Roger Faroux, F. Khemissa Akouz, Farid El Hajbi, (unknown), Yves Rinaldi, Thierry Lecomte, Sandrine Lavau‐Denès, Mathieu Baconnier, (unknown), Dominique Genet, Éléna Paillaud, (unknown), Laurent Bedenne	1
4	Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone 2015 ·European Journal of Cancer ·Julie Vincent, C. Mariette, Denis Pezet, Emmanuel Huet, Franck Bonnetain, Olivier Bouché, Thierry Conroy, Bernard Roullet, Jean‐François Seitz, (unknown), Frédéric Di Fiore, Jean–Louis Jouve, Laurent Bedenne	37
5	Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901 breakdown → 2014 ·Journal of Clinical Oncology ·C. Mariette, Laëtitia Dahan, F. Mornex, E. Maillard, P. Thomas, Bernard Meunier, Valérie Boige, Denis Pezet, William B. Robb, Valérie Le Brun-Ly, Jean-François Bosset, Jean‐Yves Mabrut, Jean–Pierre Triboulet, Laurent Bedenne, Jean‐François Seitz	413
6	Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer 2014 ·Annals of Surgery ·William B. Robb, Laëtitia Dahan, F. Mornex, E. Maillard, P. Thomas, Bernard Meunier, Valérie Boige, Denis Pezet, Valérie Le Brun-Ly, Jean-François Bosset, Jean‐Yves Mabrut, Jean–Pierre Triboulet, Laurent Bedenne, Jean‐François Seitz, C. Mariette	61
7	Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial breakdown → 2014 ·The Lancet Oncology ·Thierry Conroy, Marie‐Pierre Galais, Jean‐Luc Raoul, Olivier Bouché, S. Gourgou-Bourgade, Jean‐Yves Douillard, Pierre-Luc Etienne, Valérie Boige, Isabelle Martel‐Lafay, Pierre Michel, C. Llacer-Moscardo, E. François, G. Créhange, Méher Ben Abdelghani, Béata Juzyna, Laurent Bedenne, Antoine Adenis	276
8	Gastric Adenocarcinoma in Familial Adenomatous Polyposis Can Occur Without Previous Lesions 2013 ·Journal of Gastrointestinal Cancer ·(unknown), Laurence Faivre, (unknown), Laurent Bedenne, Sylviane Olschwang, Patrick Rat, Pablo Ortega‐Deballon	5
9	Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial breakdown → 2011 ·Journal of Clinical Oncology ·Marc Ychou, Valérie Boige, Jean‐Pierre Pignon, Thierry Conroy, Olivier Bouché, G. Lebreton, (unknown), Laurent Bedenne, (unknown), B. Saint‐Aubert, Jean Genève, P Lasser, P. Rougier	1484
10	Cancer du pancréas localement évolué non resécable : chimioradiothérapie d’induction suivie de chimiothérapie par gemcitabine contre chimiothérapie exclusive par gemcitabine : résultats définitifs de l’étude de phase III 2000–2001de la FFCD et de la SFRO 2011 ·Cancer/Radiothérapie ·(unknown), F. Mornex, (unknown), P. Rougier, C. Mariette, Olivier Bouché, J.-F. Bosset, Thomas Aparicio, Laurent Mineur, A. Azzedine, Pascal Hammel, J Butel, Noël Stremsdoerfer, P. Maingon, Laurent Bedenne, Bruno Chauffert	14
11	Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma 2010 ·European Journal of Cancer ·Franck Bonnetain, Laëtitia Dahan, E. Maillard, Marc Ychou, Emmanuel Mitry, Pascal Hammel, Jean-Louis Legoux, Philippe Rougier, Laurent Bedenne, Jean‐François Seitz	85
12	A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802) 2009 ·Annals of Oncology ·Marc Ychou, Jean‐Luc Raoul, Jean‐Yves Douillard, S. Gourgou-Bourgade, R. Bugat, Laurent Mineur, F. Viret, Y. Bécouarn, Olivier Bouché, E. Gamelin, Michel Ducreux, Thierry Conroy, Julia Seitz, Laurent Bedenne, A. Kramar	127
13	Critères de substitution: méthodes de validation et état des lieux en cancérologie digestive 2009 ·Bulletin du Cancer ·(unknown), Laurent Bedenne, Franck Bonnetain	6
14	Prise en charge des adénocarcinomes de la jonction œsogastrique résécables : quel traitement périopératoire ? 2008 ·Cancer/Radiothérapie ·G. Créhange, Franck Bonnetain, Bruno Chauffert, Paul Rat, Laurent Bedenne, P. Maingon	6
15	Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study breakdown → 2008 ·Annals of Oncology ·Bruno Chauffert, F. Mornex, (unknown), P. Rougier, C. Mariette, Olivier Bouché, J.-F. Bosset, Thomas Aparicio, Laurent Mineur, A. Azzedine, Pascal Hammel, J Butel, Noël Stremsdoerfer, P. Maingon, Laurent Bedenne	501
16	Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801) 2005 ·Annals of Oncology ·Olivier Bouché, Marc Ychou, Pascal Burtin, Laurent Bedenne, Michel Ducreux, G. Lebreton, J Baulieux, Bernard Nordlinger, C. Martin, Jean‐François Seitz, Jean‐Marie Tigaud, (unknown), Noël Stremsdoerfer, C Milan, P. Rougier	107
17	Increased cytotoxicity and stability of Lipiodol-pirarubicin emulsion compared to classical doxorubicin-Lipiodol: potential advantage for chemoembolization of unresectable hepatocellular carcinoma 2001 ·Anti-Cancer Drugs ·(unknown), Jean–Pierre Cercueil, Philippe Fauré, (unknown), Nicolás Isambert, (unknown), F. Cognet, D. Krausé, Laurent Bedenne, Bruno Chauffert	32
18	Epidemiology, management, and prognosis of malignant large bowel polyps within a defined population. 1992 ·Gut ·(unknown), Jean Faivre, M C Boutron, F Piard, Patrick Arveux, Laurent Bedenne, Patrick Hillon	21
19	L'aiguille Tru-Cut est-elle plus efficace que l'aiguille fine dans le diagnostic des lésions hépatiques? Etude comparative de 45 ponctions guidées par l'échographie. 1990 ·Gastroentérologie Clinique et Biologique ·Laurent Bedenne, (unknown), (unknown), (unknown), (unknown), Patrick Hillon, (unknown), (unknown)	2
20	Correction 1987 ·Journal of Epidemiology & Community Health ·P Renard, M C Boutron, Jean Faivre, C Milan, Laurent Bedenne, Patrick Hillon, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact